SPDR S&P Biotech ETF $XBI Shares Bought by Robertson Stephens Wealth Management LLC

Robertson Stephens Wealth Management LLC raised its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 353.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 21,391 shares of the exchange traded fund’s stock after purchasing an additional 16,673 shares during the quarter. Robertson Stephens Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $2,608,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. Capital Investment Advisory Services LLC grew its stake in SPDR S&P Biotech ETF by 4.0% during the 4th quarter. Capital Investment Advisory Services LLC now owns 2,123 shares of the exchange traded fund’s stock valued at $259,000 after purchasing an additional 81 shares during the last quarter. Compass Ion Advisors LLC grew its stake in SPDR S&P Biotech ETF by 2.6% during the 4th quarter. Compass Ion Advisors LLC now owns 3,886 shares of the exchange traded fund’s stock valued at $474,000 after purchasing an additional 97 shares during the last quarter. Moors & Cabot Inc. grew its stake in SPDR S&P Biotech ETF by 3.8% during the 3rd quarter. Moors & Cabot Inc. now owns 2,717 shares of the exchange traded fund’s stock valued at $272,000 after purchasing an additional 100 shares during the last quarter. Sequoia Financial Advisors LLC grew its stake in SPDR S&P Biotech ETF by 3.1% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 3,393 shares of the exchange traded fund’s stock valued at $340,000 after purchasing an additional 101 shares during the last quarter. Finally, Kingsview Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 1.8% during the 3rd quarter. Kingsview Wealth Management LLC now owns 5,813 shares of the exchange traded fund’s stock valued at $582,000 after purchasing an additional 103 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $130.42 on Friday. The business’s 50-day simple moving average is $127.98 and its two-hundred day simple moving average is $122.74. The company has a market cap of $8.32 billion, a PE ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a fifty-two week low of $75.68 and a fifty-two week high of $139.19.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.